preview

Performance Evaluation and Ratio Analysis of Pharmaceutical Company in Bangladesh

Decent Essays

Performance evaluation and ratio analysis of Pharmaceutical Company in Bangladesh

Faruk Hossan Md Ahsan Habib

Supervisor: José Ferraz Nunes Examiner: Bengt Kjellén

Master‟s thesis in international Business 15 ECTS Department of Economic and Informatics University West Spring term 2010

0

ABSTRACT
The thesis applies performance evaluation of pharmaceutical company in Bangladesh. It means evaluate how well the company performs. The main aim is achieved through ratio analysis of two pharmaceutical (Beximco and Square pharmaceutical) companies in Bangladesh. The main data collection from the annual financial reports on Beximco and square pharmaceutical companies in 2007 to 2008.Different financial ratio are evaluated such liquidity …show more content…

Reference 9. Appendix
Appendix-A Appendix-B Appendix-C Appendix-D Appendix-E Appendix-F

47-48 49-51 52 53-54 56-57 58 59-60 61 62 63

4

1. INTRODUCTION
This chapter gives an introduction to this thesis. A general background of the subject is followed by the thesis purpose and question, limitation of the study, thesis out line. The questions are followed by the purpose of this thesis.

1.1. Background
Performance evaluation of a company is usually related to how well a company can use it assets, share holder equity and liability, revenue and expenses. Financial ratio analysis is one of the best tools of performance evaluation of any company. In order to determine the financial position of the pharmaceutical company and to make a judgment of how well the pharmaceutical company efficiency, its operation and management and how well the company has been able to utilize its assets and earn profit.

We used ratio analysis for easily measurement of liquidity position, asset management condition, profitability and market value and debt coverage situation of the

pharmaceutical company for performance evaluation. It analysis the company use of its assets and control of its expenses. It determines the greater the coverage of liquid assets to short-term liabilities and it also compute ability to pay pharmaceutical company monthly mortgage payments from the cash generate. It measures pharmaceutical company overall efficiency and performance. It determines of share

Get Access